Supernus Pharmaceuticals
SUPN
#4465
Rank
โ‚น242.97 B
Marketcap
โ‚น4,186
Share price
1.84%
Change (1 day)
46.69%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚น141.56 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are โ‚น141.56 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚น130.40 B11.11%
2024-12-31โ‚น117.36 B10.34%
2023-12-31โ‚น106.36 B-24.5%
2022-12-31โ‚น140.88 B12.06%
2021-12-31โ‚น125.72 B14.29%
2020-12-31โ‚น110.00 B32.95%
2019-12-31โ‚น82.74 B21.02%
2018-12-31โ‚น68.37 B152.27%
2017-12-31โ‚น27.10 B28.83%
2016-12-31โ‚น21.03 B67.82%
2015-12-31โ‚น12.53 B44.6%
2014-12-31โ‚น8.66 B26.42%
2013-12-31โ‚น6.85 B33.25%
2012-12-31โ‚น5.14 B81.06%
2011-12-31โ‚น2.84 B34.93%
2010-12-31โ‚น2.10 B-43.18%
2009-12-31โ‚น3.70 B-0%
2008-12-31โ‚น3.70 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
โ‚น18.950 T 13,286.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น10.416 T 7,258.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น10.996 T 7,668.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.157 T 5,662.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚น633.35 B 347.40%๐Ÿ‡บ๐Ÿ‡ธ USA